SARCOME 13 – Randomised phase 2 trial of MEPACT combined with post-operative chemotherapy for newly diagnosed high risk osteosarcoma (metastatic or localized disease with poor histologic response)

assignment_turned_inproject

Funder: Institut National du CancerProject code: INCa-DGOS-11127 Call for proposal: PHRC16

Funded under: PHRC

SARCOME 13 – Randomised phase 2 trial of MEPACT combined with post-operative chemotherapy for newly diagnosed high risk osteosarcoma (metastatic or localized disease with poor histologic response)

- Summary
- DMPs

Partners

Institut Curie , Université de Nantes , Institut Gustave Roussy

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::be9c646812c042c99a2d846f10e2f8fe&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

SARCOME 13 – Randomised phase 2 trial of MEPACT combined with post-operative chemotherapy for newly diagnosed high risk osteosarcoma (metastatic or localized disease with poor histologic response)

SARCOME 13 – Randomised phase 2 trial of MEPACT combined with post-operative chemotherapy for newly diagnosed high risk osteosarcoma (metastatic or localized disease with poor histologic response)

Loading